ROR1 and neoplasm: To validate our results, we analyzed the GEO database (accession no. GSE87455) as shown in Fig. 1C and F. Forty-four (44/66; 67%) tumors exhibited higher expression of ROR1 than the paired pre-treatment tumor samples (Fig. 5C).